Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md., and at the Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington.

A study co-authored by Donald Leopold, M.D., UVM clinical professor of surgery, is co-focuses on phantom odors in aging Americans. According to the study, 1 in 15 Americans over the age of 40 experience smelling unpleasant scents with no apparent source.

UVM Assistant Professor of Surgery Thomas Ahern, Ph.D., is the recipient of one of 76 St. Baldrick's Foundation grants totaling more than $19.1 million to support studying innovative treatment options in the pediatric cancer space.

As the Larner College of Medicine at the University of Vermont works toward a curriculum that is 100 percent lecture-free by 2019, faculty aren’t the only ones helping move the transition forward; medical students are playing a critical role in creating active learning curriculum as well.

The University of Vermont Center on Aging and UVM Geriatric Medicine program will host a presentation, titled “Caring for Caregivers and Transitions from Hospital to Home,” by international experts Horst Vollmar, M.D., M.P.H., and Mary Austrom, Ph.D., on August 3, 2018.